91 related articles for article (PubMed ID: 2389953)
21. [Distilled water pleurodesis for two breast cancer patients suffering from carcinomatous pleurisy].
Fujishima M; Nakayama T; Tatsuta M; Yamamoto K; Kishi K; Takemoto H; Kishimoto T; Shimizu J; Imamura H; Fukunaga M; Masutani S; Kawasaki T; Furukawa H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1755-7. PubMed ID: 15553705
[TBL] [Abstract][Full Text] [Related]
22. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma.
Arinaga S; Karimine N; Takamuku K; Nanbara S; Inoue H; Nagamatsu M; Ueo H; Akiyoshi T
Int J Immunopharmacol; 1992 May; 14(4):535-9. PubMed ID: 1521921
[TBL] [Abstract][Full Text] [Related]
23. [A comparative clinical trial with tegafur plus lentinan treatment at two different doses in advanced cancer].
Wada T; Nishide T; Hatayama K; Chang SW; Tatsuta M; Yasutomi M
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2509-12. PubMed ID: 3113339
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of lymphocyte subset change as an indicator for predicting survival time and effectiveness of treatment with the immunopotentiator lentinan.
Matsuoka H; Yano K; Seo Y; Saito T; Tomoda H; Tsurumoto S
Anticancer Res; 1995; 15(5B):2291-6. PubMed ID: 8572640
[TBL] [Abstract][Full Text] [Related]
25. [Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group].
Wakui A; Kasai M; Konno K; Abe R; Kanamaru R; Takahashi K; Nakai Y; Yoshida Y; Koie H; Masuda H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1050-9. PubMed ID: 3083785
[TBL] [Abstract][Full Text] [Related]
26. [Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion].
Li DJ
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):294-6. PubMed ID: 2625114
[TBL] [Abstract][Full Text] [Related]
27. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
Kosaka A; Wani T; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1474-81. PubMed ID: 6764117
[TBL] [Abstract][Full Text] [Related]
28. [A gastric cancer showing marked improvement (stage IV) with lentinan immunotherapy and 5-FU, MMC-chemotherapy].
Horiguchi M; Saito A; Sonoda H
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1973-7. PubMed ID: 2838002
[TBL] [Abstract][Full Text] [Related]
29. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
30. [Combination use of lentinan with X-ray therapy in a mouse experimental tumor system (Part I). Basic studies].
Shiio T; Tsuchiya Y; Ohishi K; Yoshihama T
Gan To Kagaku Ryoho; 1988 Feb; 15(2):313-7. PubMed ID: 3341791
[TBL] [Abstract][Full Text] [Related]
31. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.
Gordon M; Bihari B; Goosby E; Gorter R; Greco M; Guralnik M; Mimura T; Rudinicki V; Wong R; Kaneko Y
J Med; 1998; 29(5-6):305-30. PubMed ID: 10503166
[TBL] [Abstract][Full Text] [Related]
32. [Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor].
Moriya N; Miwa H; Taketsuka S; Orita K
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1646-52. PubMed ID: 6870308
[TBL] [Abstract][Full Text] [Related]
33. [Change of blood lentinan level in patients with advanced cancers].
Yajima Y; Satoh J; Kikuchi T; Fukuda I; Toyota T; Saito H; Okabe N; Suzuki H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2633-8. PubMed ID: 2774594
[TBL] [Abstract][Full Text] [Related]
34. [Lentinan].
Taguchi T
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3294-304. PubMed ID: 3777966
[No Abstract] [Full Text] [Related]
35. [Immunological assay of the CA-125 value in pleural effusion in various types of pleuritis--its application as a differential diagnostic parameter of tuberculous or carcinomatous pleuritis].
Mitsutake Y; Hiromatsu Y; Saisho M; Tokunaga N; Ichikawa Y; Kaji M; Irie K
Gan No Rinsho; 1986 May; 32(5):453-7. PubMed ID: 3459902
[TBL] [Abstract][Full Text] [Related]
36. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
Taguchi T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Efficacy and Safety for Lentinan in the Control of the Malignant Pleural Effusions via Intrapleural Injection.
Congcong Q; Hengting Z; Shuhui L; Fang Y; Shan W
Am J Med Sci; 2019 Dec; 358(6):400-411. PubMed ID: 31813467
[TBL] [Abstract][Full Text] [Related]
38. [Scanning electron microscopic observation of mouse ascitic carcinoma cells after intraperitoneal administration of lentinan].
Kurokawa T; Tamakuma S
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2822-7. PubMed ID: 2074392
[TBL] [Abstract][Full Text] [Related]
39. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
Akimoto M; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
Suga T; Shiio T; Maeda YY; Chihara G
Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
